Wed, Apr 16, 2014, 8:06 AM EDT - U.S. Markets open in 1 hr 24 mins

Recent

% | $
Quotes you view appear here for quick access.

ViroPharma Inc. Message Board

  • nuhawkus nuhawkus Sep 14, 2012 1:14 PM Flag

    Kamoa

    Nice find on the license. Question - the description says Schering Plough is responsible for development of the intranasal formulation of pleconaril. The sepsis trial was using the oral form. Do you think that perhaps VPHM would still have the rights to the oral form or is it clear they are with SP (Merck)?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I believe they've turned over everything to Schering-Plough including the oral formulation. Should Schering, now a part of Merck, makes anything out of this compound (pleconaril) including the treatment for the H1N1 virus they are on the hook for royalty fees... that is imo.

      aloha,
      kamoa

 
VPHM
49.960.00(0.00%)Jan 23 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.